Oxford spinout MiroBio acquired by Gilead Sciences for $405m

Published on August 4, 2022

The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.
Continue reading on website
Other news

Daily Record: Lanarkshire village Trust manager appointed as a Fellow at the University of Cambridge

August 4, 2022
Glenboig Development Trust’s operational manager Teresa Aitken has been appointed as a Fellow at Cambridge Judge Business School.Teresa is “delighted” to have the Cambridge Judge/Faculty of Social Innovation honour bestowed upon her, the article says.Read the full article [dailyrecord.co.uk]The post Daily Record: Lanarkshire village Trust manager appointed as a Fellow at the University of Cambridg

Antimicrobial resistant bacteria found in newborn children from low- and middle-income countries

August 5, 2022
Sepsis is a primary cause of mortality in newborns, particularly in low- and middle-income countries (LMICs). A new study coordinated by Professor Tim Walsh at the Ineos Oxford Institute for Antimicrobial Research (IOI) and Department of Biology looks at the links between the presence of bacteria resistant to antibiotics isolated from mothers and their newborn babies living across 7 LMICs in Afric